Technical analysis of Citius Pharmaceuticals, Inc. (CTXR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies.
Price Performance
| 1 month | -2.06% |
| 3 months | +2.49% |
| Year-to-date | -27.93% |
| 1 year | -52.54% |
| 3 years | -96.95% |
| 5 years | -98.92% |
52-Week Range
| 52-week High | $2.19 |
| 52-week Low | $0.47 |
| Avg Volume (90d) | 571K |
Technical Indicators
| SMA 50 | $0.59 |
| SMA 200 | $0.74 |
| Beta | 1.38 |
| 30-day Volatility (annualised) | 138.5% |
| Price vs SMA 50 | -5.5% |
| Price vs SMA 200 | -24.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.58 | |
| 2025-11 | $1.44 | -8.9% |
| 2025-12 | $0.78 | -46.0% |
| 2026-01 | $0.74 | -4.7% |
| 2026-02 | $0.74 | -0.0% |
| 2026-03 | $0.90 | +21.6% |
| 2026-04 | $0.70 | -22.7% |
| 2026-05 | $0.65 | -5.9% |
| 2026-06 | $0.60 | -7.7% |
| 2026-07 | $0.57 | -5.7% |
| 2026-08 | $0.58 | +1.8% |
| 2026-09 | $0.56 | -3.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.56 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.21 |
| EV / EBITDA | 0.06 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.11 |
| Current Ratio | 0.84 |